Melatonina Aurovitas

Melatonin, the active ingredient in Melatonina Aurovitas, is a melatonin receptor agonist presented as an oral formulation for oral use. It is employed to support the regulation of circadian rhythm and to promote sleep onset in adults experiencing sleep disturbances.

GNH USA supplies Melatonina Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards, is manufactured under GMP conditions, and is distributed through regulated channels to ensure product integrity and traceability.

Melatonina Aurovitas acts on the melatonin pathway to address sleep‑related disorders.

Insomnia: helps initiate and maintain sleep in individuals with difficulty falling asleep. Delayed sleep phase disorder: assists in advancing sleep timing to a more conventional schedule. Jet lag: reduces the time required to adjust the internal clock after rapid time‑zone travel.

Melatonina Aurovitas may be associated with several adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Daytime sleepiness: feeling unusually drowsy during waking hours. - Nausea: mild gastrointestinal discomfort. - Vivid dreams: unusually intense or memorable dreaming. - Mild abdominal discomfort: occasional stomach upset.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or angioedema requiring medical attention. - Depression: worsening mood or depressive symptoms. - Seizures: rare occurrence in predisposed individuals. - Hormonal effects: potential impact on reproductive hormone balance. - Severe hypersensitivity: anaphylaxis requiring emergency care.

When considering Melatonina Aurovitas, several safety measures should be observed. - Evaluate sleep hygiene: ensure non‑pharmacologic measures are optimized before use. - Avoid use in shift‑work schedules: may interfere with circadian adaptation. - Monitor in patients with depression: melatonin can influence mood. - Use caution in the elderly: increased risk of falls due to daytime drowsiness. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Melatonin can interact with various medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines): may enhance sedation. - Anticoagulants (e.g., warfarin): potential alteration of bleeding risk. - Immunosuppressants (e.g., cyclosporine): may affect drug concentrations.

Moderate Interactions (Monitor Closely): - Oral contraceptives: melatonin may reduce contraceptive efficacy. - Antihypertensives: additive blood‑pressure‑lowering effect. - Caffeine: may diminish melatonin’s sleep‑promoting action.